After five years, Nido Biosciences has reached the end of the road, closing its doors after its lead neurological disease ...

Carvykti, a CAR-T therapy co-developed by Legend Biotech & J&J, is central to second-line multiple myeloma treatment. Both firms are actively scaling up production across bases. Carvykti sales surged ...

Forbes contributors publish independent expert analyses and insights. Jim Osman is a finance expert with over 30 years of experience. As an investor, my greatest returns have usually come from areas ...

Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of ...

In The Star's annual year in review, the county's biggest business stories included housing proposals and the aftermath of a ...

Maryland officials said more than 500 jobs will be retained at the site, with new employment opportunities and additional ...

Sana Biotechnology is a biotech company focused on developing engineered allogeneic cells for diseases with unmet clinical needs. Sana's most advanced product candidates leverage CRISPR technology to ...

Evercrisp Biosciences, Inc., a portfolio company of Apple Tree Partners, entered bankruptcy within a month of a filing by ...

IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health ...

Investing in biotechnology stocks has always required a high risk tolerance and the patience to wait years, even decades, for results. These companies drive medical innovation, developing therapies ...